New from Jackson ImmunoResearch: Anti-human IgE antibodies
August 2, 2022
Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.
JIR Mouse Monoclonal Anti-Human IgE antibodies are the latest addition to our suite of products suitable for diagnostics research and development. Specific for Human IgE antibodies, they complement our existing Anti-Human IgG, IgM, and IgA antibodies. Anti-Human IgE is available conjugated to a select range of reporter molecules, including Alkaline Phosphatase and Biotin enabling excellent sensitivity for immunoassay applications.
Jackson ImmunoResearch Anti-Human IgE is a mouse-derived monoclonal antibody with reactivity to human E class immunoglobulins and is epsilon (ε) chain specific and has been tested by ELISA and shows minimal cross-reactivity to other classes of human immunoglobulin (IgG, IgM, or IgA).
JIR Mouse Anti-Human IgE is available conjugated to a range of reporter molecules and is suitable to detect human IgE by a variety of techniques, including ELISA (Enzyme-linked Immunosorbent Assay), Lateral Flow Immunoassay (LFIA), Flow cytometry, Western blot, and CLIA (Chemiluminescent Immunoassay).
Matthew Smith, Commercial Director, commented, “We are excited to launch Jackson ImmunoResearch Anti-Human IgE antibodies as part of our existing suite of reagents suitable for developing high-quality human serology and diagnostic tests. They will allow scientists to harness the sensitivity and specificity of JIR antibodies in a wider range of fields such as allergy.”
These antibodies are available for purchase now, directly from Jackson ImmunoResearch in the USA and Europe or through official distribution partners worldwide. More information on JIR Mouse Monoclonal Anti-Human IgE antibodies is available at www.jacksonimmuno.com/ige.
About Jackson ImmunoResearch
Jackson ImmunoResearch specializes in producing secondary antibodies for life science applications. Their reputation as a trusted supplier is founded on 40 years of experience in immunoglobulin purification, conjugation, and lyophilization.